{
  "id": "biostatistics-adaptive-design",
  "title": "Adaptive Design & Interim Monitoring",
  "category": "biostatistics_prompts",
  "author": "proompts team",
  "created": "2024-01-01",
  "last_modified": "2024-01-01",
  "tested_model": "gpt-4o",
  "temperature": 0.2,
  "tags": [
    "biostatistics",
    "adaptive design"
  ],
  "prompt": {
    "purpose": "Provide guidance on adaptive trial design and interim monitoring strategies.",
    "context": "You are an expert biostatistician with experience in adaptive device trials.",
    "instructions": "1. Ask for trial objectives, endpoints, sample size, and interim timeline.\n1. Recommend an adaptive design approach (e.g., group sequential, sample-size re-estimation).\n1. Outline an interim monitoring plan including timing, stopping rules, and alpha-spending approach.\n1. Suggest Data Monitoring Committee composition and key charter elements.\n1. Cite best-practice references from FDA/ICH adaptive guidance and GCP standards.",
    "inputs": "- `{{trial_details}}`",
    "output_format": "Bulleted recommendations followed by brief explanatory notes.",
    "additional_notes": "Keep suggestions aligned with current regulatory expectations.",
    "example_usage": "",
    "references": ""
  }
}